1. Academic Validation
  2. Molecular mechanism of staurosporine-induced apoptosis in osteoblasts

Molecular mechanism of staurosporine-induced apoptosis in osteoblasts

  • Pharmacol Res. 2000 Oct;42(4):373-81. doi: 10.1006/phrs.2000.0700.
H J Chae 1 J S Kang J O Byun K S Han D U Kim S M Oh H M Kim S W Chae H R Kim
Affiliations

Affiliation

  • 1 Department of Dental Pharmacology and Wonkwang Dental Research Institute, Iksan, Chonbuk, Japan.
Abstract

Staurosporine, a microbial alkaloid, is a strong inhibitor of protein kinases. We induced Apoptosis in murine osteoblast MC3T3E-1 cells by exposure to the staurosporine. Staurosporine transiently increased the phosphotransferase activity of c-Jun N-terminal kinase-1 (JNK1), which in turn may activate the transcriptional activity of activating protein-1 (AP-1). We then prepared extracts from staurosporine-treated MC3T3E-1 cells and monitored the cleavage of acetyl-YVAD-AMC and acetyl-DEVD-AMC, fluorogenic substrates of caspase-1-like and caspase-3-like proteases, respectively. Staurosporine caused a significant increase in the proteolytic activity of caspase-3-like proteases, but not in the activity of caspase-1-like proteases. Furthermore, staurosporine increased the transcriptional activity of nuclear factor- kappa B (NF- kappa B). These data suggest that staurosporine-induced Apoptosis in osteoblasts may occur via activation of JNK1, caspase-3-like proteases, and transcriptional factors including AP-1 and NF- kappa B.

Figures
Products